维普期刊资源整合服务平台（V6.5）

212篇 您的检索式：作者名="Burnier"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document显示文摘	Giuseppe Mancia Stéphane Laurent Enrico Agabiti-Rosei Ettore Ambrosioni Michel Burnier Mark J Caulfield Renata Cifkova Denis Clément Antonio Coca Anna Dominiczak Serap Erdine Robert Fagard Csaba Farsang Guido Grassi Hermann Haller Anthony Heagerty Sverre	2009	Journal of Hypertension2009，，：	2
2	Treatment of essential hy- pertension with calcium channel blockers:what is the place of lercanidipine 显示文摘	Burnier M Pruijm M Wuerzner G	2009	Expert Opin Drag Metab Toxicol2009，8，5：	1
3	Novel mechanisms for activatedprotein C cytoprotective activities involving noncanonicalactivation of protease-activated receptor 3显示文摘	Burnier L Mosnier LO	2013	Blood2013，122，5：	1
4	Medication adherence and persistence as the cornerstone of effective antihypertensive therapy显示文摘	Burnier M	2006	Am J Hypertens2006，19，11：	1
5	Body mass index,abdominal adiposity,and blood pressure:Consistencey of their association across developing and developed countries显示文摘	Doll S Paccaud F Burnier M	2002	Int J Obes Relat Metab Disord2002，26，：	1
6	Circadian variations in blood pressure: Im- plications for chronotherapeutics显示文摘	Hassler C Burnier M	2005	Am J Cardiovase Drugs2005，5，1：	1
7	High Prevalence of Anti‐Apolipoprotein/A‐1 Autoantibodies in Maintenance Hemodialysis and Association With Dialysis Vintage显示文摘	Menno Pruijm Jan Schmidtko Anthony Aho Sabrina Pagano Pascale Roux‐Lombard Daniel Teta Michel Burnier Nicolas Vuilleumier	2012	Therapeutic Apheresis and Dialysis2012，，6：	1
8	Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document显示文摘	Giuseppe Mancia Stéphane Laurent Enrico Agabiti-Rosei Ettore Ambrosioni Michel Burnier Mark J. Caulfield Renata Cifkova Denis Clément Antonio Coca Anna Dominiczak Serap Erdine Robert Fagard Csaba Farsang Guido Grassi Hermann Haller Antony Heagerty Sverre	2009	Blood Pressure2009，，6：	1
9	Telmisartan/hydrochlorothiazide: a new fixed dose combination 显示文摘	MAILLARD M BURNIER M	2005	Expert Rev Cardiovasc Ther2005，3，3：	1
10	Comparative safety and tolerability of angiotension Ⅱ receptor antagonists显示文摘	Burnier M	1999	Drug Safety1999，21，：	1
11	Hypertension therapy in pa-tients with renal artery stenosis显示文摘	Vogt B Maillard M Burnier M	2012	Ther Umsch2012，69，5：	1
12	Cell-derived mierop- articles in haemostasis and vascular medicine 显示文摘	Burnier L Fontana P Kwak B R	2009	Thromb Haemost2009，101，3：	1
13	Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy显示文摘	ANGELILLO-SCHERRER A BURNIER L FLO-RES N	2005	J Clin Invest2005，115，：	1
14	Blockade of the rennin-angiotesinaldosterone system:A key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes显示文摘	Burnier M Zanchi A	2006	J Hypertens2006，24，1：	1
15	Pharmacokinetic and pharmacodynarnic effects of YM087,a combined V1/V2 vasopressin receptor antagonist in normal subjects显示文摘	Burnier M Fricker AF Hayoz D	1999	Eur J Clin Pharmacol1999，55，9：	1
16	Histopathological Study of Delayed Regraft After Corneal Graft Failure显示文摘	Leonardo N Santos Leticia Rielo de Moura Bruno F Fernandes Devinder P Cheema Miguel N Burnier	2011	Cornea2011，，2：	1
17	Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?显示文摘	MAILLARD MP BURNIER M	2007	Vasc Health Risk Manag2007，3，3：	1
18	Role ofGas6 receptors in platelet signaling during thrombus stabili-zation and implications for antithrombotic therapy显示文摘	Angelillo-Scherrer A Burnier L Flores N	2005	JClin Invest2005，115，2：	1
19	Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines显示文摘	Logan P Burnier J Burnier M N Jr		0，，336：	1
20	Angiotensin II type 1 receptor blockers显示文摘	Burnier M	2001	Circula-tion2001，103，：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示